SCHEMBL2434811

SCHEMBL2434811

Fc1ccnc(NC2CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ L3MBTL1 Q9Y468 1/20 0.53
▸ MAPK1 P28482 1/20 0.50
▸ MALT1 Q9UDY8 1/20 0.49
▸ MAPK14 Q16539 8/20 0.48
▸ HRH4 Q9H3N8 3/20 0.44
▸ HCRTR2 O43614 1/20 0.41
▸ CCNT1 O60563 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ USP2 O75604 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CSNK1D P48730 1/20 0.40
▸ NOS3 P29474 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22570017 0.87 KDM4E (0.47) ALDH1A1KDM4EL3MBTL1MAPK1MALT1
SCHEMBL23573503 0.86 MAPK14 (0.46) ALDH1A1KDM4EL3MBTL1MAPK1MALT1
SCHEMBL2710597 0.77 ALDH1A1 (0.53) ALDH1A1KDM4EL3MBTL1MAPK1MALT1
SCHEMBL16974188 0.77 ALDH1A1 (0.53) ALDH1A1KDM4EL3MBTL1MAPK1MALT1
SCHEMBL827883 0.77 ALDH1A1 (0.83) ALDH1A1KDM4EL3MBTL1MAPK1MALT1
SCHEMBL12465906 0.73 CDC7 (0.51) ALDH1A1KDM4EL3MBTL1MAPK1MAPK14
SCHEMBL14804466 0.73 ALDH1A1 (0.53) ALDH1A1KDM4EL3MBTL1MAPK1MALT1
SCHEMBL18232562 0.73 MAPK1 (0.57) ALDH1A1KDM4EL3MBTL1MAPK1MALT1
SCHEMBL24473806 0.73 ALDH1A1 (0.49) ALDH1A1KDM4EL3MBTL1MAPK1MALT1
SCHEMBL24473804 0.72 HCAR3 (0.61) ALDH1A1KDM4EL3MBTL1MAPK14NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2545050-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C Bristol-Myers Squibb Company (US) 2013-01-16 — — EP disclosed
WO-2011112186-A1 COMPOUNDS FOR THE TREATMENT OF HEPATITIS C BRISTOL-MYERS SQUIBB COMPANY (US) 2011-09-15 — — WO disclosed
Send feedback